American actress Demi Moore appeared at the 32nd Actor Awards, formerly known as the Screen Actors Guild Awards, at the Shrine Auditorium and Expo Hall in Los Angeles.

The market for weight-loss drugs is booming - but the pioneer in the field is shedding profits and share value, writes Adam Maguire

Amanda Bynes is already turning heads with her weight loss -- but don’t get it twisted, she’s not done yet! Sources close to Amanda tell TMZ she’s dropped from 180 pounds down to 151 ...

Amanda Bynes was out and about living her best life ... and while she was at it, she dropped a little fitspo reminder ... showing off nearly 30 pounds of weight loss.

A $200 million pea protein business is reportedly thriving by catering to the 'Ozempic generation,' indicating a shift in dietary trends.

The Bronx native previously credited hitting the gym & eating healthy.

Novo Nordisk announced plans to reduce the U.S. list prices for its popular diabetes and weight-loss drugs, Ozempic and Wegovy, by up to 50%. This move aims to make the medications more affordable for patients.

Novo Nordisk announced significant reductions, up to 50%, in the U.S. list prices for its popular drugs Ozempic and Wegovy.

Novo Nordisk is reducing the list price of its weight-loss drug Wegovy and diabetes drug Ozempic in the USA to improve patient access.

Shares of Novo Nordisk, owner of Wegovy and Ozempic, fell sharply after its highly anticipated next-generation weight-loss drug, CagriSema, failed to meet investor expectations in testing, leading it to be branded 'obsolete'.

The World Anti-Doping Agency (WADA) is investigating whether weight-loss drugs like Ozempic should be banned for athletes ahead of the 2028 Olympic Games due to concerns about potential misuse and health risks.

Celebrity chef Gordon Ramsay criticizes restaurants for adopting Ozempic-inspired menus, calling the GLP-1-influenced dining trend 'stupid' and 'embarrassing'.

The Wall Street Journal likens the disruptive effect of Ozempic on the pharmaceutical industry to the 'Napster moment' for music, highlighting its significant market impact.

Ireland’s prominent tailor, Louis Copeland, attributes a significant increase in sales to the 'Ozempic effect,' as men who have lost weight using the drug are now purchasing new, smaller wardrobes.

A researcher associated with Ozempic has reportedly stepped away and is now advocating for increased cabbage consumption, suggesting a focus on dietary changes.

Berberine has gained popularity as a 'plant equivalent' to weight-loss drugs like Ozempic. Researchers from Wrocław Medical University are reviewing its efficacy to determine if it's a scientific breakthrough or a myth.

The rise of appetite-suppressing drugs like Ozempic is expected to change consumer habits, leading to less ultra-processed foods, smaller portions, and more protein in grocery baskets.

Danish pharmaceutical giant Novo Nordisk announced a significant 50% price reduction in the United States for its leading obesity and diabetes medications, Wegovy and Ozempic.

Novo Nordisk to Cut U.S. List Prices for Ozempic, Wegovy by Up to 50%  WSJ

The Mayrlife clinic in Aussee celebrates its 10th anniversary, highlighting its F. X. Mayr fasting program and its approach to GLP-1 medications like Ozempic.

Novo Nordisk’s study showing a new drug wasn’t as good as a rival’s led one sell-side analyst to downgrade the stock for the first time in five years.

Henrik Due, 50, opted for gastric bypass surgery over Ozempic after struggling with weight despite intense training, successfully losing 26 kilos and now training five days a week a year post-operation.

Experts are raising alarms about the misuse of the drug Ozempic for weight loss, cautioning that people are choosing an easy path to shed pounds, potentially jeopardizing their health.

How Ozempic Brought a Napster Moment to Big Pharma  The Wall Street Journal

Οι θαυμαστές της Ντέμι Μουρ αιφνιδιάστηκαν όταν η χολιγουντιανή σταρ εμφανίστηκε στην Εβδομάδα Μόδας του Μιλάνου με ένα total black δερμάτινο σύνολο που προκάλεσε καταιγισμό σχολίων στα social…

The article discusses whether popular weight-loss drugs like Ozempic and Mounjaro are covered by insurance in the UAE, a growing concern for patients.

Ozempic and similar weight-loss medications are hailed as miracle drugs. But there are plenty of unknowns about long-term use.

Eli Lilly is preparing to release orforglipron, a new once-daily GLP-1 pill, which has shown an average of 15-20 pounds of weight loss in clinical trials for people with diabetes.

An article discusses obesity treatment, emphasizing that it involves more than just medications like Ozempic and simple weight loss, highlighting the importance of long-term health maintenance and the body's resistance to weight reduction.

Despite being first to launch a GLP-1 drug for weight loss, Novo's market share has eroded, and the company now only captures about 40% of the market.

Novo Nordisk announced plans to reduce the U.S. list prices for its popular diabetes and weight-loss drugs, Ozempic and Wegovy, by up to 50%.

Novo Nordisk plans to reduce the prices of its popular weight-loss and diabetes drugs, Ozempic and Wegovy, starting in 2027, a move that could impact patient access and market dynamics.

Novo Nordisk’s shares fall sharply after testing of CagriSema falls short of investors’ expectations

An article explores the Canadian ties to the Ozempic drug, often associated with the weight loss industry, as part of a series titled 'Skinny, Inc.'

A high-flying device maker is reportedly well-positioned to succeed regardless of which weight loss drug, such as Ozempic, ultimately dominates the market.

An article discusses Novo Nordisk's new diabetes drug and its potential to outperform Ozempic, analyzing the stock's investment potential.